Product Information
Name:ITI-214
Brand:Biosynth
Description:ITI-214 is a new drug that has been shown to have a number of potential therapeutic uses. It has been shown to inhibit locomotor activity, which may be due to its ability to inhibit the release of calcium from the sarcoplasmic reticulum. ITI-214 also inhibits cyclic nucleotide phosphodiesterases, which are enzymes that break down cyclic nucleotides and thereby regulate cellular function. This inhibition leads to an increase in intracellular levels of cAMP, leading to enhanced physiological function. ITI-214 has been shown to have anti-cancer effects in vitro and in vivo. It also enhances the efficacy of cancer treatments such as radiation therapy and chemotherapy, by inhibiting tumor growth and enhancing immune responses against cancer cells. The mechanism by which ITI-214 exerts these effects is not yet known but may be related to its ability to inhibit Ercc1, a gene associated with hereditary colon cancer susceptibility or other genes involved in DNA repair pathways.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:507.6 g/mol
Formula:C29H26FN7O
Purity:Min. 95%
Technical inquiry about: ITI-214
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.